Benzinga - Gainers
- Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.
- Evaxion Biotech A/S (NASDAQ: EVAX) rose 34.4% to $2.38 in pre-market trading. Evaxion Biotech said on Dec 22, the FDA notified the company that it had reviewed the company's IND for Phase 2b clinical trial of EVX-01 in combination with Keytruda.
- Sesen Bio, Inc. (NASDAQ: SESN) shares rose 30.4% to $0.6590 in pre-market trading after the company and Carisma Therapeutics announced an increased special dividend of $70 million, or $0.34 per share, in connection with the pending merger.
- Tuesday Morning Corporation (NASDAQ: TUEM) rose 22.8% to $0.84 in pre-market trading after gaining around 16% on Thursday. Tuesday Morning recently announced it will voluntarily delist from the Nasdaq Capital Market.
- Landos Biopharma, Inc. (NASDAQ: LABP) rose 17.7% to $0.60 in pre-market trading after gaining 12% on Thursday.
- Palisade Bio, Inc. (NASDAQ: PALI) rose 17.1% to $3.77 in pre-market trading after jumping 78% on Thursday. Palisade Bio recently provided an update on its U.S. Phase 2 study evaluating LB1148 for the reduction in intra-abdominal adhesions in subjects following elective bowel resection.
- Lightning eMotors, Inc. (NYSE: ZEV) shares rose 16.3% to $0.38 in pre-market trading. Lightning eMotors recently received continued listing standards notice from NYSE.
- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) rose 15% to $0.5997 in pre-market trading.
- Getaround, Inc. (NYSE: GETR) rose 14% to $0.5702 in pre-market trading after dropping around 8% on Thursday. Piper Sandler initiated coverage on Getaround with an Overweight rating and announced a price target of $1.5.
- ASAP, Inc. (NASDAQ: ASAP) rose 12.3% to $0.38 in pre-market trading.
- Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 11.1% to $1.60 in pre-market trading after surging 21% on Thursday.
- Panbela Therapeutics, Inc. (NASDAQ: PBLA) rose 11% to $0.0810 in pre-market trading after dropping 11% on Thursday. Panbela Therapeutics recently filed prospectus for public offering for up to 4.7 million shares of common stock.
- Shaw Communications Inc. (NYSE: SJR) rose 10.3% to $29.11 in pre-market trading. Canada's competition tribunal approved Rogers Communications’ $14.8 billion offer for Shaw Communications.
- National CineMedia, Inc. (NASDAQ: NCMI) rose 9.3% to $0.26 in pre-market trading.
Losers
- Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares fell 32.8% to $7.20 in pre-market trading. Hoth Therapeutics shares jumped around 144% on Thursday after the FDA accepted the IND application for HT-001.
- Argo Blockchain plc (NASDAQ: ARBK) fell 18.3% to $0.7387 in pre-market trading after gaining 23% on Thursday. Argo Blockchain recently entered into definitive agreements with Galaxy Digital Holdings, under which an Argo subsidiary will sell its Helios facility in Dickens County, Texas for $65 million.
- Pineapple Energy Inc (NASDAQ: PEGY) fell 7% to $1.88 in pre-market trading after jumping 22% on Thursday. EF Hutton recently initiated coverage on Pineapple Energy with a Buy rating and announced a price target of $5.5.
- Baudax Bio, Inc. (NASDAQ: BXRX) fell 6.4% to $3.36 in pre-market trading after jumping around 56% on Thursday. Baudax Bio recently announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery.
- Rubius Therapeutics, Inc. (NASDAQ: RUBY) shares fell 6.4% to $0.18 in pre-market trading after declining around 20% on Thursday. Rubius Therapeutics, last month, initiated a process to explore a range of strategic alternatives and plans to engage an investment bank to act as a strategic advisor for this process.
- Esports Entertainment Group, Inc. (NASDAQ: GMBL) fell 6.3% to $0.0780 in pre-market trading after gaining 5% on Thursday. Esports Entertainment Group recently announced registered direct offering, private placement.
- Quotient Limited (NASDAQ: QTNT) fell 5.5% to $0.3497 in pre-market trading after jumping 54% on Thursday.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.